MAP3K5 and Hepatic fibrosis: The observations partly mimic results of Yoon et al. study, which demonstrated that selonsertib alleviates liver fibrosis via blocking ASK1/MAPK pathway in hepatic stellate cells (Yoon et al., 2020).